.

follow-on-google-news

On March 28, 2025, 9 stocks reached their 20 percent upper limit even in the sideways market. This shows that investors are willing to take risks, but these stocks can be volatile, so thorough research is essential.

Punjab Chemicals & Crop Protection Limited

With a market capitalization of Rs. 1,168 crores, the shares of Punjab Chemicals & Crop Protection Limited surged by 20 percent, reaching an upper circuit of Rs. 1,006.80 per share on Friday, up from its previous closing price of Rs. 839 per share. Since then, the stock has retreated and is currently trading at Rs. 926.95 per equity share.

The company is a leading manufacturer of agrochemicals, pharmaceuticals, and specialty chemicals. The company has a strong global presence, catering to diverse industries with a focus on innovation and sustainability. It continues to expand its product portfolio and market reach, driving consistent growth.

Innovana Thinklabs Limited

With a market capitalization of Rs. 609 crores, the shares of Innovana Thinklabs Limited surged by 20 percent, reaching an upper circuit of Rs. 329.80 per share on Friday, up from its previous closing price of Rs. 274.85 per share. Since then, the stock has retreated and is currently trading at Rs. 296.95 per equity share.

Innovana Thinklabs Limited is a technology company specializing in software development, digital products, and IT solutions. It focuses on cybersecurity, utility software, and mobile applications for global markets. The company continues to expand its digital offerings, leveraging innovation and technology-driven solutions.

Vaishali Pharma Limited

With a market capitalization of Rs. 135 crores, the shares of Vaishali Pharma Limited surged by 20 percent, reaching an upper circuit of Rs. 12.58 per share on Friday, up from its previous closing price of Rs. 10.49 per share. Since then, the stock is currently trading at Rs. 12.58 per equity share.

Vaishali Pharma Limited is a pharmaceutical company engaged in manufacturing, exporting, and supplying a wide range of healthcare products. It specializes in formulations, APIs, surgical products, and nutraceuticals, serving global markets. The company focuses on quality, innovation, and expanding its international footprint.

Generic Engineering Construction and Projects Limited

With a market capitalization of Rs. 164 crores, the shares of Generic Engineering Construction and Projects Limited surged by 20 percent, reaching an upper circuit of Rs. 28.72 per share on Friday, up from its previous closing price of Rs. 23.94 per share. Since then, the stock is currently trading at Rs. 28.72 per equity share.

Generic Engineering Construction and Projects Limited is a construction company specializing in civil and structural engineering across residential, commercial, and industrial sectors. It focuses on high-quality execution, timely delivery, and innovative building solutions. The company continues to expand its presence in India’s growing infrastructure sector.

Sarthak Metals Limited

With a market capitalization of Rs. 164 crores, the shares of Sarthak Metals Limited surged by 20 percent, reaching an upper circuit of Rs. 118.92 per share on Friday, up from its previous closing price of Rs. 99.10 per share. Since then, the stock is currently trading at Rs. 118.92 per equity share.

Sarthak Metals Limited is a leading manufacturer of cored wires, aluminum flipping coils, and ferro alloys for the steel industry. The company focuses on innovation, quality, and efficiency to enhance steel production processes. It continues to expand its market presence both domestically and internationally.

Zenith Drugs Limited

With a market capitalization of Rs. 123 crores, the shares of Zenith Drugs Limited surged by 20 percent, reaching an upper circuit of Rs. 71.70 per share on Friday, up from its previous closing price of Rs. 59.75 per share. Since then, the stock is currently trading at Rs. 71.70 per equity share.

Zenith Drugs Limited is a pharmaceutical company specializing in the manufacturing and distribution of high-quality medicines. It focuses on formulations across various therapeutic segments, ensuring affordability and efficacy. The company continues to expand its market reach with a commitment to innovation and compliance.

Dangee Dums Limited

With a market capitalization of Rs. 76.8 crores, the shares of Dangee Dums Limited surged by 20 percent, reaching an upper circuit of Rs. 4.99 per share on Friday, up from its previous closing price of Rs. 4.16 per share. Since then, the stock has retreated and is currently trading at Rs. 4.99 per equity share.

Dangee Dums Limited is a bakery and confectionery brand known for its premium cakes, pastries, and desserts. It operates a retail chain, offering a wide range of innovative and high-quality baked products. The company continues to expand its presence in the Indian market with a focus on taste and customer satisfaction.

Paramount Dye Tec Limited

With a market capitalization of Rs. 39.4 crores, the shares of Paramount Dye Tec Limited surged by 20 percent, reaching an upper circuit of Rs. 56.80 per share on Friday, up from its previous closing price of Rs. 47.35 per share. Since then, the stock is currently trading at Rs. 56.80 per equity share.

Paramount Dye Tec Limited is a manufacturer and supplier of high-quality dyes and chemicals for the textile and related industries. The company focuses on innovation, sustainability, and efficiency to meet diverse customer needs. It continues to expand its market presence with a commitment to quality and eco-friendly solutions.

Vilin Bio Med Limited

With a market capitalization of Rs. 28.5 crores, the shares of Vilin Bio Med Limited surged by 20 percent, reaching an upper circuit of Rs. 20.40 per share on Friday, up from its previous closing price of Rs. 17.00 per share. Since then, the stock is currently trading at Rs. 20.40 per equity share.

Vilin Bio Med Limited is a pharmaceutical and healthcare company engaged in the manufacturing and distribution of medicines, medical devices, and wellness products. It focuses on innovation, affordability, and quality to cater to diverse healthcare needs. The company continues to expand its presence in domestic and international markets.

Written by Satyajeet Mukherjee

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

×